| Mrs Mary Veronica Kinerk, MS, CCC-SLP | |
|
33914 19th Ave Sw, Federal Way, WA 98023-8007 | |
| (253) 945-5021 | |
| Not Available |
| Full Name | Mrs Mary Veronica Kinerk |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 33914 19th Ave Sw, Federal Way, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174950364 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 00003095 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Mary Veronica Kinerk, MS, CCC-SLP 11427 30th Pl Sw, Seattle, WA 98146-3465 Ph: (253) 945-5021 | Mrs Mary Veronica Kinerk, MS, CCC-SLP 33914 19th Ave Sw, Federal Way, WA 98023-8007 Ph: (253) 945-5021 |
News Archive
Curemark LLC, a drug research and development company focused on the treatment of neurological diseases, announced today that it has been awarded a grant by the United States government under the Qualifying Therapeutic Discovery Project (QTDP) Program to advance the development of its lead product CM-AT for autism. CM-AT is presently in Phase III clinical trials at 18 sites around the US.
Today, the U.S. Food and Drug Administration is taking two new, important steps to increase competition in the market for prescription drugs and facilitate entry of lower-cost alternatives.
Experts have spent decades warning us about the rising rates of childhood obesity, which has become an epidemic among recent generations in many places around the world, including Spain.
A closer examination of these health plans (to be offered on the California and Oregon exchanges) reveals a less rosy picture. Although the premiums are lower than some anticipated, this has been achieved by designing the plans around much more limited provider networks and including greater cost-sharing than the typical commercial health-insurance plan. The premiums for the policies that will be offered on the states' exchanges are much higher than analogous plans being sold today (Daniel P. Kessler, 6/3).
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has successfully completed its acquisition of Dionex Corporation through a short-form merger.
› Verified 4 days ago
Breanna Elizabeth Serdahl, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 33330 8th Ave S, Federal Way, WA 98003 Phone: 253-945-2810 | |
Sheila J Winkler, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 33501 1st Way S, Federal Way, WA 98003 Phone: 253-838-2400 | |
Ms. Eva Day Wulff, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 33330 8th Ave S, Federal Way, WA 98003 Phone: 253-945-2086 Fax: 253-945-2177 | |
Emily Foster, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 33330 8th Ave S, Federal Way, WA 98003 Phone: 253-945-2000 | |
Vivian Hsueh, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1010 S 336th St, Ste. 210, Federal Way, WA 98003 Phone: 253-835-5769 | |
Ms. Deirdre Marie Curle, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 35535 6th Ave Sw, Federal Way, WA 98023 Phone: 253-874-5445 Fax: 253-874-0687 | |
Jennifer Guth, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 35999 16th Ave S, Federal Way, WA 98003 Phone: 253-945-3170 Fax: 253-945-2177 |